StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
4026
This month
36
This week
30
This year
1301
Today
3
Yesterday
15
Publishing Date
2023 - 12 - 06
12
2023 - 11 - 28
11
2023 - 11 - 06
11
2023 - 11 - 03
20
2023 - 10 - 31
12
2023 - 10 - 23
19
2023 - 10 - 04
16
2023 - 10 - 03
13
2023 - 09 - 28
11
2023 - 09 - 27
17
2023 - 09 - 11
12
2023 - 05 - 25
14
2023 - 04 - 19
14
2023 - 04 - 18
17
2023 - 04 - 17
18
2023 - 03 - 15
19
2023 - 03 - 14
27
2022 - 12 - 08
16
2022 - 12 - 01
11
2022 - 11 - 10
19
2022 - 10 - 12
11
2022 - 10 - 06
12
2022 - 10 - 05
20
2022 - 09 - 12
12
2022 - 06 - 06
11
2022 - 04 - 13
10
2022 - 04 - 12
10
2022 - 04 - 11
10
2022 - 04 - 08
29
2022 - 03 - 09
11
2022 - 03 - 08
37
2022 - 03 - 07
13
2022 - 02 - 17
11
2022 - 01 - 20
10
2022 - 01 - 18
18
2021 - 12 - 13
10
2021 - 12 - 10
18
2021 - 12 - 09
18
2021 - 11 - 30
12
2021 - 11 - 12
17
2021 - 11 - 09
15
2021 - 10 - 28
12
2021 - 10 - 25
11
2021 - 10 - 13
10
2021 - 10 - 07
19
2021 - 10 - 04
12
2021 - 10 - 01
29
2021 - 09 - 30
14
2021 - 09 - 20
13
2021 - 09 - 14
10
2021 - 06 - 04
12
2021 - 06 - 03
11
2021 - 05 - 21
10
2021 - 05 - 20
15
2021 - 04 - 12
20
2021 - 04 - 10
16
2021 - 04 - 09
16
2021 - 04 - 08
11
2021 - 03 - 10
17
2020 - 12 - 09
14
Sector
Administrative and support and waste management and remediation services
6
Commercial services
89
Communications
130
Consumer durables
7
Consumer non-durables
17
Consumer services
17
Distribution services
19
Electronic technology
18
Energy minerals
4
Finance
57
Finance and insurance
3
Health care and social assistance
1
Health services
234
Health technology
2908
Industrial services
1
Information
5
Manufacturing
339
Mining, quarrying, and oil and gas extraction
6
Miscellaneous
2
N/a
114
Non-energy minerals
9
Process industries
19
Producer manufacturing
3
Professional, scientific, and technical services
123
Real estate and rental and leasing
1
Retail trade
9
Technology services
62
Transportation
2
Utilities
3
Wholesale trade
3
Tags
Acquisition
7902
Agreement
2564
Application
2285
Approval
2292
Business
3501
Cancer
4026
Ceo
2419
Ces
2928
Collaboration
2259
Conference
21681
Corporation
5051
Covid
2710
Deadline
3796
Disease
2544
Distribution
2891
Drug
2624
Earnings
3575
Energy
7244
Europe
2306
Events
4714
Fda
3276
Financial
13171
Financial results
8251
Global
10327
Group
4504
Growth
12168
Health
4734
International
2073
Management
2419
Market
21736
Media
2149
Meeting
3087
N/a
266564
Nasdaq
3513
Offering
6977
Partnership
2612
People
2349
Pharma
2260
Pharmaceuticals
2401
Platform
2170
Positive
2842
Presentation
2961
Program
3581
Report
14257
Research
9950
Results
39074
Sales
2125
Services
2727
Solutions
2412
Spac
2312
Study
2289
System
2460
Technology
6333
Test
2335
Therapeutics
8522
Therapy
2774
Treatment
4972
Trial
6718
Update
4392
Year
4903
Entities
Abbott laboratories
41
Abbvie inc.
48
Accuray incorporated
23
Agilent technologies, inc.
25
Amgen inc.
81
Angle plc
22
Anixa biosciences, inc.
46
Astellas pharma inc
39
Astrazeneca plc
130
Aveo pharmaceuticals, inc.
24
Becton, dickinson and company
24
Beigene, ltd.
53
Biocept, inc.
31
Blueprint medicines corporation
27
Briacell therapeutics corp.
42
Bristol-myers squibb company
102
Castle biosciences, inc.
28
Clovis oncology, inc.
33
Eli lilly and company
128
Exact sciences corporation
52
Exelixis, inc.
42
G1 therapeutics, inc.
26
Genprex, inc.
24
Gilead sciences, inc.
58
Glaxosmithkline plc
50
Guardant health, inc.
50
Hologic, inc.
30
Hoth therapeutics, inc.
27
Illumina, inc.
62
Immunitybio inc
27
Immunogen, inc.
23
Immutep limited
31
Incyte corporation
55
Invitae corporation
25
Jaguar health, inc.
34
Johnson & johnson
116
Karyopharm therapeutics inc.
27
Koninklijke philips n.v.
20
Lantern pharma inc.
24
Merck & company, inc.
69
Merus n.v.
22
Mirati therapeutics, inc.
31
Myriad genetics, inc.
47
Nanostring technologies, inc.
21
Natera, inc.
33
Novartis ag
95
Novocure limited
28
Oncolytics biotech inc.
39
Orange
130
Pds biotechnology corporation
34
Pfizer, inc.
58
Qiagen n.v.
27
Regeneron pharmaceuticals, inc.
41
Sanofi
181
Seagen inc.
54
Takeda pharmaceutical company limited
30
Thermo fisher scientific inc
46
Veracyte, inc.
44
Verastem, inc.
21
Viewray, inc.
21
Symbols
A
25
ABBV
48
ABT
41
ALPMF
39
ALPMY
39
AMGN
81
ANIX
46
ARAY
23
AVEO
24
AZN
130
AZNCF
67
BCTX
42
BDX
24
BGNE
53
BIOC
31
BMY
102
BPMC
27
CLVS
33
CSTL
28
EXAS
52
EXEL
42
FNCTF
130
GH
50
GILD
58
GLAXF
42
GNPX
24
GSK
50
GTHX
26
HOLX
30
HOTH
27
IBRX
27
ILMN
62
IMGN
23
IMMP
31
INCY
55
JAGX
34
JNJ
116
KPTI
27
LLY
128
LTRN
24
MRK
69
MRTX
31
MRUS
22
MYGN
47
NTRA
33
NVCR
28
NVS
95
NVSEF
81
NVTA
25
ONCY
39
PDSB
34
PFE
58
QGEN
27
REGN
41
SGEN
54
SNY
181
SNYNF
131
TAK
30
TMO
46
VCYT
44
Exchanges
Amex
65
Lse
27
Nasdaq
3564
Nyse
833
Tsx
18
Crawled Date
2023 - 12 - 06
12
2023 - 11 - 28
11
2023 - 11 - 06
11
2023 - 11 - 03
19
2023 - 10 - 31
12
2023 - 10 - 23
19
2023 - 10 - 04
16
2023 - 10 - 03
13
2023 - 09 - 27
17
2023 - 09 - 11
12
2023 - 05 - 25
14
2023 - 04 - 19
14
2023 - 04 - 18
17
2023 - 04 - 17
18
2023 - 03 - 15
19
2023 - 03 - 14
26
2022 - 12 - 08
17
2022 - 12 - 01
11
2022 - 11 - 10
19
2022 - 10 - 12
11
2022 - 10 - 06
12
2022 - 10 - 05
20
2022 - 09 - 12
13
2022 - 06 - 06
11
2022 - 04 - 08
29
2022 - 03 - 09
13
2022 - 03 - 08
34
2022 - 03 - 07
13
2022 - 02 - 17
11
2022 - 01 - 19
14
2022 - 01 - 18
12
2021 - 12 - 13
10
2021 - 12 - 10
20
2021 - 12 - 09
15
2021 - 11 - 30
12
2021 - 11 - 12
17
2021 - 11 - 09
14
2021 - 10 - 28
12
2021 - 10 - 25
11
2021 - 10 - 13
10
2021 - 10 - 07
19
2021 - 10 - 04
12
2021 - 10 - 01
32
2021 - 09 - 30
11
2021 - 09 - 20
13
2021 - 09 - 14
10
2021 - 09 - 13
10
2021 - 06 - 04
12
2021 - 06 - 03
11
2021 - 05 - 21
10
2021 - 05 - 20
14
2021 - 04 - 13
10
2021 - 04 - 12
18
2021 - 04 - 10
15
2021 - 04 - 09
16
2021 - 04 - 08
11
2021 - 03 - 21
11
2021 - 03 - 10
16
2020 - 12 - 09
14
2020 - 12 - 01
21
Crawled Time
00:00
75
00:20
16
01:00
64
02:00
20
03:00
14
04:00
8
04:20
8
05:00
18
06:00
28
06:03
2
07:00
35
08:00
36
08:20
6
09:00
50
10:00
45
11:00
205
11:33
3
12:00
461
12:01
4
12:03
4
12:05
2
12:06
2
12:15
61
12:20
100
12:30
56
13:00
449
13:01
6
13:02
3
13:04
6
13:05
3
13:15
61
13:20
109
13:30
67
14:00
361
14:01
5
14:03
3
14:15
22
14:20
62
14:30
66
15:00
193
15:01
3
15:15
12
15:20
32
15:30
25
16:00
145
16:20
45
17:00
118
18:00
112
19:00
115
20:00
124
20:20
16
21:00
153
21:03
3
22:00
159
22:01
5
22:04
6
22:14
3
22:15
6
22:17
3
23:00
111
Source
adnas.com
1
contravir.com
3
feed.businesswire.com
1
investor.alkermes.com
7
investor.aveooncology.com
2
investors.phiopharma.com
6
investors.senseibio.com
8
ir.anaptysbio.com
3
ir.biolinerx.com
5
ir.chemocentryx.com
1
ir.hoththerapeutics.com
4
ir.sunesis.com
1
ir.vaccinex.com
4
jaguarhealth.gcs-web.com
27
mdxhealth.com
8
myriad.com
1
nanthealth.com
5
renovorx.com
12
salariuspharma.com
1
spacfeed.com
9
www.4dpharmaplc.com
2
www.4frontventures.com
1
www.adnas.com
1
www.affimed.com
2
www.allogene.com
3
www.anpacbio.com
6
www.atossatherapeutics.com
2
www.beyondspringpharma.com
4
www.biospace.com
1836
www.celyad.com
2
www.chi-med.com
2
www.cuebiopharma.com
1
www.curevac.com
1
www.emmis.com
1
www.fatetherapeutics.com
9
www.fda.gov
30
www.gflenv.com
1
www.globenewswire.com
1117
www.hepionpharma.com
2
www.hutch-med.com
2
www.igmbio.com
2
www.immatics.com
3
www.immunogen.com
5
www.immunoprecise.com
2
www.innodata.com
1
www.kuraoncology.com
9
www.limoneira.com
4
www.luminexcorp.com
1
www.mdu.com
1
www.myriad.com
5
www.nanthealth.com
5
www.nantkwest.com
18
www.novocure.com
5
www.nurixtx.com
5
www.phiopharma.com
1
www.poseida.com
6
www.precisionbiosciences.com
1
www.prnewswire.com
797
www.sutrobio.com
10
www.vermillion.com
4
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
tags :
Cancer
save search
Merck Announces KEYLYNK-008 Trial Evaluating KEYTRUDA® (pembrolizumab) Plus LYNPARZA® (olaparib) for Patients With Metastatic Squamous Non-Small Cell Lung Cancer to Stop for Futility
Published:
2023-12-07
(Crawled : 18:00)
- biospace.com/
MRK
|
News
|
$103.88
-1.66%
0.02%
9.1M
|
Health Technology
|
-2.21%
|
O:
-0.61%
H:
0.01%
C:
-1.61%
ylynk-008
keytruda
lung
merck
cancer
cell
trial
plus
Cogent Biosciences Presents New Preclinical Data Highlighting Potential Best-in-Class Potency and Selectivity of ErbB2 and PI3Kα inhibitor programs at the San Antonio Breast Cancer Symposium
Published:
2023-12-07
(Crawled : 14:30)
- globenewswire.com
COGT
|
News
|
$8.75
1.74%
1.71%
1.1M
|
Health Technology
|
4.31%
|
O:
4.31%
H:
0.0%
C:
0.0%
breast
symposium
cancer
preclinical
potential
Exact Sciences Awards Grants to 23 Organizations Focused on Increasing Colorectal Cancer Screenings
Published:
2023-12-07
(Crawled : 13:00)
- prnewswire.com
EXAS
|
News
|
$64.96
-0.31%
-0.31%
930K
|
Health Technology
|
-1.11%
|
O:
-0.64%
H:
0.25%
C:
-0.47%
cancer
awards
sciences
grants
Anixa Biosciences and Cleveland Clinic Present Positive New Data from Phase 1 Study of Breast Cancer Vaccine
Published:
2023-12-06
(Crawled : 23:00)
- prnewswire.com
ANIX
|
$3.6
-8.4%
-9.17%
1.1M
|
Health Technology
|
-10.45%
|
O:
0.0%
H:
5.63%
C:
-10.45%
vaccine
breast
positive
cancer
study
Validation Data on a Novel Prognostic Test Developed by GRAIL in Stage I Lung Cancer Presented at North America Conference on Lung Cancer
Published:
2023-12-06
(Crawled : 22:00)
- biospace.com/
ILMN
|
News
|
$117.085
2.72%
2.64%
2.1M
|
Health Technology
|
4.8%
|
O:
1.56%
H:
0.0%
C:
0.0%
AZN
|
$63.5
-0.14%
-0.14%
6.2M
|
Health Technology
|
-0.78%
|
O:
0.77%
H:
0.0%
C:
0.0%
america
lung
conference
test
cancer
Metastatic Castration-Sensitive Prostate Cancer Market to Skyrocket at Astounding 22% CAGR During the Study Period (2019-2032), assesses DelveInsight
Published:
2023-12-06
(Crawled : 22:00)
- prnewswire.com
LLY
6 d
|
$588.27
-0.17%
-0.1%
2.1M
|
Health Technology
|
-0.07%
|
O:
-0.06%
H:
0.1%
C:
-0.0%
cancer
study
market
Anixa Biosciences to Host Conference Call This Evening to Discuss Positive New Data from Ongoing Phase 1 Study of Breast Cancer Vaccine
Published:
2023-12-06
(Crawled : 21:00)
- prnewswire.com
ANIX
|
$3.6
-8.4%
-9.17%
1.1M
|
Health Technology
|
-10.45%
|
O:
0.0%
H:
5.63%
C:
-10.45%
conference
vaccine
breast
positive
cancer
ongoing
study
How CNS Pharmaceuticals Is Taking A Different Approach To Find A Treatment For Glioblastoma, A Cancer With A Poor Prognosis And No Cure
Published:
2023-12-06
(Crawled : 17:00)
- biospace.com/
CNSP
|
$2.05
-2.38%
-2.44%
37K
|
Health Technology
|
-0.94%
|
O:
0.47%
H:
0.0%
C:
0.0%
cure
cancer
treatment
pharmaceuticals
BriaCell Highlights Outstanding Topline Survival and Clinical Benefit Data in Advanced Metastatic Breast Cancer at the 2023 SABCS
Published:
2023-12-06
(Crawled : 14:30)
- globenewswire.com
BCTX
|
$4.9
-3.16%
-3.27%
67K
|
Professional, Scientific, and T...
|
-6.88%
|
O:
-0.76%
H:
0.0%
C:
0.0%
breast
cancer
sabcs
topline
advanced
Study Data on Quality of Life for Breast Cancer Patients and Survivors, Supported by Napo Pharmaceuticals (a Jaguar Health Family Company), Published on San Antonio Breast Cancer Symposium (SABCS) Website
Published:
2023-12-06
(Crawled : 14:30)
- biospace.com/
JAGX
|
$0.2863
-10.53%
-11.77%
4.2M
|
Health Technology
|
-11.27%
|
O:
-1.54%
H:
0.0%
C:
0.0%
breast
health
life
symposium
cancer
pharmaceuticals
family
study
Natera Presents New Signatera™ MRD Data Across Breast Cancer Treatment Settings at SABCS 2023
Published:
2023-12-06
(Crawled : 14:30)
- biospace.com/
NTRA
S
|
$57.93
0.05%
0.05%
680K
|
Health Services
|
-0.58%
|
O:
1.01%
H:
0.0%
C:
0.0%
breast
cancer
treatment
sabcs
TUKYSA® (tucatinib) in Combination with Antibody-Drug Conjugate ado-Trastuzumab Emtansine Improves Progression-Free Survival in Patients with Previously Treated HER2-Positive Metastatic Breast Cancer
Published:
2023-12-06
(Crawled : 14:30)
- biospace.com/
SGEN
|
$218.28
1.15%
1.14%
2M
|
Health Technology
|
0.09%
|
O:
0.09%
H:
0.0%
C:
0.0%
tukysa
breast
cancer
Celcuity Presents Preclinical Data on Therapeutic Effects of Gedatolisib in Breast Cancer Models at the 2023 San Antonio Breast Cancer Symposium
Published:
2023-12-06
(Crawled : 13:30)
- globenewswire.com
CELC
|
$14.72
-1.8%
-1.83%
150K
|
Commercial Services
|
-2.18%
|
O:
-1.02%
H:
0.0%
C:
0.0%
breast
symposium
cancer
preclinical
Bionano Announces Presentations Featuring OGM Utility Across Blood Cancer Research at the American Society of Hematology (ASH) Annual Meeting
Published:
2023-12-06
(Crawled : 13:00)
- globenewswire.com
BNGO
|
$1.505
-9.88%
-10.96%
1.7M
|
Health Technology
|
-5.0%
|
O:
-5.0%
H:
0.0%
C:
0.0%
cancer
blood
research
meeting
Arvinas to Host Conference Call and Webcast to Discuss Vepdegestrant (ARV-471) Data Presented at 2023 San Antonio Breast Cancer Symposium and Plans to Expand Vepdegestrant Development Program
Published:
2023-12-06
(Crawled : 04:00)
- globenewswire.com
PFE
A
|
$28.63
-0.56%
0.0%
35M
|
Health Technology
|
-1.82%
|
O:
-0.21%
H:
0.0%
C:
0.0%
ARVN
|
$32.71
7.95%
7.37%
1.6M
|
Health Technology
|
36.89%
|
O:
1.93%
H:
0.0%
C:
0.0%
arv-471
conference
breast
symposium
cancer
program
Fallopian Tube Cancer Therapeutics Market size to grow by USD 832.01 million from 2023-2028| AbbVie Inc., Amgen Inc., Arrien Pharmaceuticals LLC and more among the key companies in the market - Technavio
Published:
2023-12-05
(Crawled : 23:00)
- prnewswire.com
NVS
|
News
1 d
|
$95.93
-1.15%
0.0%
1.2M
|
Health Technology
|
-1.42%
|
O:
0.17%
H:
0.0%
C:
0.0%
GSK
|
$36.0
-0.47%
0.06%
2.2M
|
Health Technology
|
-0.91%
|
O:
0.03%
H:
0.0%
C:
0.0%
ABBV
|
News
|
$147.97
1.09%
0.05%
7.2M
|
Health Technology
|
2.35%
|
O:
0.26%
H:
0.0%
C:
0.0%
AZN
|
$63.5
-0.14%
-0.14%
6.2M
|
Health Technology
|
-0.78%
|
O:
0.77%
H:
0.0%
C:
0.0%
GOOGL
|
$136.94
5.32%
5.05%
55M
|
Technology Services
|
4.72%
|
O:
1.97%
H:
0.0%
C:
0.0%
GOOG
|
$138.415
5.32%
5.05%
38M
|
Technology Services
|
4.82%
|
O:
1.97%
H:
0.0%
C:
0.0%
tube
companies
abbvie
cancer
pharmaceuticals
therapeutics
market
FDA Grants Priority Review of ImmunoGen’s Supplemental Biologics License Application for ELAHERE® (mirvetuximab soravtansine-gynx) in Platinum-Resistant Ovarian Cancer
Published:
2023-12-05
(Crawled : 18:00)
- biospace.com/
IMGN
M
|
$29.355
0.05%
0.05%
12M
|
Health Technology
|
Email alert
Add to watchlist
elahere
fda
license
review
cancer
application
grants
TransCode Therapeutics To Present Phase 0 Data at 2023 San Antonio Breast Cancer Symposium
Published:
2023-12-05
(Crawled : 14:00)
- globenewswire.com
RNAZ
3 d
|
$0.2085
-9.35%
-10.31%
1.6M
|
Professional, Scientific, and T...
|
-10.71%
|
O:
1.91%
H:
0.0%
C:
0.0%
breast
symposium
cancer
therapeutics
ABVC BioPharma Shares Insights from Dr. Scott Irwin of Cedars-Sinai Medical Center over Depression in Cancer Patients Clinical Trials
Published:
2023-12-05
(Crawled : 13:30)
- globenewswire.com
ABVC
|
News
|
$1.24
-8.15%
-8.87%
430K
|
Wholesale Trade
|
-9.42%
|
O:
5.07%
H:
1.38%
C:
-0.69%
irwin
cancer
depression
biopharma
trials
medical
Hoth Therapeutics Announces it Has Successfully Completed Manufacturing of its Cancer fighting HT-KIT for IND-Enabling Studies
Published:
2023-12-05
(Crawled : 13:30)
- prnewswire.com
HOTH
|
$1.29
4.03%
3.88%
140K
|
Health Technology
|
6.56%
|
O:
1.64%
H:
12.1%
C:
4.84%
cancer
therapeutics
← Previous
1
2
3
4
5
6
7
8
9
…
201
202
Next →
Gainers vs Losers
69%
31%
Top 10 Gainers
SLDB
|
News
M
|
$5.89
72.22%
41.94%
12M
|
Health Technology
SVFD
|
News
|
$3.09
43.72%
30.42%
64M
|
FTEL
|
$2.04
43.66%
30.39%
110K
|
HPCO
4
|
$0.4824
41.92%
29.54%
28M
|
ALGS
|
News
|
$0.6475
-5.06%
26.67%
2.1M
|
Health Technology
GTHX
|
$3.16
30.58%
23.42%
10M
|
Health Technology
KEQU
|
$22.5
27.62%
21.64%
24K
|
Producer Manufacturing
GSIT
|
$3.09
27.16%
21.36%
2.2M
|
Electronic Technology
SSKN
P
|
$0.628
25.6%
20.38%
210K
|
Health Technology
GLUE
|
$3.66
22.82%
18.58%
510K
|
Professional, Scientific, and T...
Your saved searches
Save your searches and get alerts when important news are released.